cystic fibrosis transmembrane conductance regulator (505-511) has been researched along with fenamic acid in 1 studies
| Studies (cystic fibrosis transmembrane conductance regulator (505-511)) | Trials (cystic fibrosis transmembrane conductance regulator (505-511)) | Recent Studies (post-2010) (cystic fibrosis transmembrane conductance regulator (505-511)) | Studies (fenamic acid) | Trials (fenamic acid) | Recent Studies (post-2010) (fenamic acid) |
|---|---|---|---|---|---|
| 17 | 1 | 3 | 324 | 1 | 44 |
| Protein | Taxonomy | cystic fibrosis transmembrane conductance regulator (505-511) (IC50) | fenamic acid (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 1.51 | |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 0.44 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quinton, PM; Reddy, MM | 1 |
1 other study(ies) available for cystic fibrosis transmembrane conductance regulator (505-511) and fenamic acid
| Article | Year |
|---|---|
Effect of anion transport blockers on CFTR in the human sweat duct.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Anions; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Electric Conductivity; Glyburide; Humans; In Vitro Techniques; Male; Membrane Potentials; Nitrobenzoates; ortho-Aminobenzoates; Peptide Fragments; Phosphorylation; Reproducibility of Results; Sensitivity and Specificity; Stilbenes; Sweat Glands | 2002 |